Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News EUFEPS Network on Dermatopharmacy just founded 22nd PKPD Expertentreffen in the heart of the Black Forest 3rd GBHI in Amsterdam: lively discussions and intensive exchange with authorities Meet us in Amsterdam: 3rd GBHI Conference starts soon (12 – 13 April 2018) Meet us in Munich: AGAH Annual Meeting 26 – 27 April 2018 Regorafenib: first in human as eye drops Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Elpro Biosimilars Xerostomia Subcontractor qualification Statistical programming Hormone replacement therapy HTA SOP based Ovulation inhibition Pharmacology Metered dose inhaler Pilot study Clinical Monitoring Dry powder inhaler Statistical Analysis Plan Standardisation Phase IIa trials MMM Patch Competence Safety Bioavailability GCP COPD Absorption CRF Design development Dermal irritation Biometrics TTS DFI Gynaecological trials Investigators brochure EMA Intensive assessment station Pharmacodynamic studies Data Management Plan Glaucoma Thuringia Post authorisation Pulse oximetry plethysmography Postmenopausal women Statistical services Efficacy Authorities Dose linearity Sore throat Oncology Steady state Inspection Axis Audit Experience MCID Pharmacokintetics Source Data Verification Phase I Unit Phase II Informed Consent Procedure SDV Phase IV Clinical study IMPD Oncologic network Referral system Quality Paediatricians CDISC HPA axis PASS Monitoring FDA Drug Food Interaction DUS Ophthalmological trials Clinical pharmacology unit In vitro in vivo correlation Adrenocortical Phase III Project Management IEC Female adolescents Ophthalmologist Absorption windows Data management Charcoal Pituitary Quality Assurance Clinical development program Life cycle management Sample size estimation GLP Scientific expertise Pharmacokinetics Standard operating procedure Non interventional Ophthalmology Children Slit lamp microscopy Allergy Hypothalamic Biopharmaceutics Protocol Copyright Phase IIb trials Cardiovascular surveillance HRT FIM Immunogenicity Highly variable drugs Training Uveitis Cough Bioequivalence Spacious archive Patients Oncological patients Healthy subjects Contraception Dry eye Rhine Main area SAS Edema Database MDI ANVISA Auditing Eye disease DPI Pragmatism Creativity Endpoint Transdermal therapeutic system First in human Good Clinical Practice Sequential designs DDI Anaesthesiologist Ocular tolerability SocraTec C&S Drug Drug Interaction Local tolerability Asthma Patient recruitment CDASH Quality Management System CDSIC GCP training CRA ADAM Scientific advice AGAH Recruitment rates Expert Data Validation Plan Degeneration Legal Information Product development Consultancy Sensitisation trials US FDA PAES WinNonlin Central surveillance system Clinical trials ICF Early phase OTC Network Biopharmaceutical US CFR 21 Part 11 IB Legal representative Lung Patch adhesion NIS Common cold Centralised procedure Inhalatives CRO Macular IVIVC Phase I CDM Protocol development Feasibility  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page